Cardiology Activities
The Role of the Pharmacist With Cholesterol Management: Focusing on New Guidelines and PCSK9 Inhibitors
0290-0000-19-153-H01-P
This activity reviews the new cholesterol guidelines and highlights the role and evidence supporting the use of PCSK9 inhibitors in the treatment of hypercholesterolemia.
2.00
Improving Patient Access to PCSK9 Inhibitors: The Role of the Pharmacist
0290-0000-19-165-H01-P
This on-demand webinar will outline the role of PCSK9 inhibitors in the treatment of hypercholesterolemia including mechanism of action and potential adverse effects.
0.50
Novel Advances in Hereditary ATTR Amyloidosis: Payer and Specialty Pharmacy Considerations
0290-0000-19-103-H01-P
This program will analyze data supporting the use of current and emerging therapies for the treatment of hATTR.
1.50
PCSK9 Inhibitors: Managing Hypercholesterolemia and Improving Patient Outcomes
0290-0000-19-109-H01-P
This program will analyze the most recent cost-effectiveness data for the use of PCSK9 inhibitors.
1.50